US FDA approves Celcuity's breast cancer drug
CELC•FDA approves Celcuity drug for advanced breast cancer
July 14 (Reuters) - The U.S. Food and Drug Administration has approved Celcuity's CELC.O drug for an advanced form of breast cancer, the regulator said on Tuesday, making it the company's first product to gain market entry.
